Literature DB >> 11053211

Beta-agonist-induced constitutive beta(2)-adrenergic receptor activity in bovine tracheal smooth muscle.

B de Vries1, H Meurs, A F Roffel, C R Elzinga, B H Hoiting, M M de Vries, J Zaagsma.   

Abstract

According to the two state receptor model, the beta(2)-adrenergic receptor (beta(2)-AR) isomerizes between an inactive state and a constitutively active state, which couples to the stimulatory G-protein in the absence of agonist. In bovine tracheal smooth muscle (BTSM), we investigated the effect of short and long term beta(2)-AR activation by fenoterol on constitutive receptor activity. Preincubation of the BTSM strips for 5 min, 30 min and 18 h with 10 microM fenoterol, followed by extensive washout (3 h, 37 degrees C), caused a rapid and time-dependent inhibition of KCl-induced contraction, reaching 68+/-10, 51+/-6 and 46+/-4% of control, respectively, at 40 mM KCl (P:<0.05 all). At all time points, the EC(50) values to KCl were significantly reduced as well. Preincubation of BTSM with 0.1, 1.0 and 10 microM fenoterol during 18 h caused a concentration-dependent decrease of the 40 mM KCl response to 70+/-5, 47+/-12 and 43+/-9% of control, respectively (P:<0.05 all). The reduced KCl contractions were reversed in the presence of 1 microM timolol. Moreover, the sensitivity to KCl in the presence of timolol was enhanced after fenoterol incubation. Inverse agonism was also found for other beta-blockers, with a rank order of efficacy of pindolol >/=timolol=propranolol>alprenolol>/=sotalol>labetalol. At 25 mM KCl-induced tone, the contraction induced by cumulative timolol administration was competitively antagonized by the less efficacious inverse agonist labetalol, indicating that the fenoterol-induced effects cannot be explained by residual beta-agonist binding. In conclusion, fenoterol treatment of BTSM causes a time- and concentration-dependent development of constitutive beta(2)-AR activity, which can be reversed by various inverse agonists. The beta-agonist-induced changes could represent a novel regulation mechanism of beta(2)-AR activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053211      PMCID: PMC1572420          DOI: 10.1038/sj.bjp.0703664

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?

Authors:  D MacKay
Journal:  J Pharm Pharmacol       Date:  1978-05       Impact factor: 3.765

2.  Further evidence that naloxone acts as an inverse opiate agonist: implications for drug dependence and withdrawal.

Authors:  S L Cruz; J E Villarreal; N D Volkow
Journal:  Life Sci       Date:  1996-05-24       Impact factor: 5.037

3.  Evidence for a direct relationship between phosphoinositide metabolism and airway smooth muscle contraction induced by muscarinic agonists.

Authors:  H Meurs; A F Roffel; J B Postema; A Timmermans; C R Elzinga; H F Kauffman; J Zaagsma
Journal:  Eur J Pharmacol       Date:  1988-11-01       Impact factor: 4.432

4.  Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.

Authors:  P Samama; G Pei; T Costa; S Cotecchia; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

5.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Authors:  P Samama; S Cotecchia; T Costa; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

6.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.

Authors:  A De Lean; J M Stadel; R J Lefkowitz
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

7.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.

Authors:  C A Milano; L F Allen; H A Rockman; P C Dolber; T R McMinn; K R Chien; T D Johnson; R A Bond; R J Lefkowitz
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

8.  Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.

Authors:  Z Wang; E J Bilsky; F Porreca; W Sadée
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

9.  Inverse agonist activity of beta-adrenergic antagonists.

Authors:  P Chidiac; T E Hebert; M Valiquette; M Dennis; M Bouvier
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

10.  A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated.

Authors:  G Pei; P Samama; M Lohse; M Wang; J Codina; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more
  2 in total

1.  A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes.

Authors:  Martin C Michel; Martina B Michel-Reher; Peter Hein
Journal:  Cells       Date:  2020-08-19       Impact factor: 6.600

2.  Pharmacodynamic Study of Interaction of Aqueous Leaf Extract of Psidium Guajava Linn. (Myrtaceae) with Receptor Systems Using Isolated Tissue Preparations.

Authors:  R K Mahaseth; S Kumar; Shagun Dutta; Ratika Sehgal; Preety Rajora; Rajani Mathur
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.